Oncology
Worries about the trend of breast cancer in India
Increasing incidence of BC in younger age groups
The rising number of cases of breast cancer in India
Late presentation: This directly decreases the long-term survival of the patient
Lack of awareness and Screening: Breast Awareness (Being aware of symptoms of BC, looking out for them regularly, and reporting them on time to a doctor) is the single most important factor responsible for better survival of patients in the west
Aggressive cancers in young: Generally, many cancers in the younger age group tend to be aggressive.
Increasing incidence of BC in younger age groups (30s and 40s)
As per the ICMR data, India had 14 lakh cancer patients in 2016 and this number is expected to increase. The government has laid down four priority cancers — breast cancer, cervical cancer, oral cancer, and lung cancer which together constitute 41 percent of cancer burden, the report mentioned.
“Breast cancer is currently the most common cancer among Indian women, both in terms of incidence as well as mortality, with proportional prevalence in younger age-groups being higher than the global average. Age-standardized rate is approximately 25.8 per one lakh women and is expected to rise to 35 per one lakh women in 2026,” the report stated.
Non Invasive image guided breast Brachytherapy is one of the most desired treatments available in the worlds leading Cancer institutes.
AccuBoost ®️ is a non-invasive way to deliver radiation to the site of breast cancer lumpectomy post surgery. AccuBoost ® is an innovation in breast radiotherapy that enables radiation oncologists to target their boost dose to lumpectomy cavity – the tissue that is the most likely site of future cancer recurrence. Treatment enabled by AccuBoost ®️ technology combines a non-invasive method of delivering a targeted beam with the power of real-time image guidance to deliver the radiation dose accurately and reliably to the surgical excision site. Additionally, the AccuBoost ®️ process strongly limits unintentional exposure to otherwise healthy tissue (such as heart, lungs and chest wall) and minimizes radiation-related side effects.
Traditionally, the boost dose, a stronger localized dosage of radiation, is targeted to surgical site using only the surgical scar as an indicator of location. With AccuBoost ®️, the same technology used in mammograms is used to pinpoint the location of the tumour site within the breast. With the breast slightly pulled away from the body as in mammography the boost dose is delivered precisely to the area of lumpectomy from for different angles using the guidance of AccuBoost ®️ real-time digital imaging.
